DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
- Status
- COMPLETED
- Phase
- PHASE3
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)
- Status
- COMPLETED
- Phase
- PHASE1
Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)
- Status
- COMPLETED
- Phase
- NA
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
- Status
- COMPLETED
- Phase
- PHASE3
Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong
- Status
- WITHDRAWN
- Phase
- N/A
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prospective Tissue Collection Research Protocol
- Status
- COMPLETED
- Phase
- N/A
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
- Status
- WITHDRAWN
- Phase
- PHASE1
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation)
- Status
- COMPLETED
- Phase
- N/A
COMBACTE-CDI Understanding the Burden of C. Difficile Infection
- Status
- COMPLETED
- Phase
- N/A
An Early Access Programme for Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A